Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996-2001
- PMID: 11787575
Item in Clipboard
Fever, jaundice, and multiple organ system failure associated with 17D-derived yellow fever vaccination, 1996-2001
MMWR Morb Mortal Wkly Rep.
.
Free article
Abstract
At the June 2001 meeting of the Advisory Committee for Immunization Practices (ACIP), seven cases of multiple organ system failure (MOSF) in recipients of 17D-derived yellow fever (YF) vaccine were presented. In response, an ACIP working group was formed to review the cases, assess the risk for serious adverse events following YF vaccination, and consider revision of the 1990 YF vaccination recommendations. This notice summarizes these cases and describes an enhanced surveillance program designed to refine risk estimates and improve histopathologic documentation of MOSF potentially associated with YF vaccination.
Similar articles
-
Adverse events associated with 17D-derived yellow fever vaccination--United States, 2001-2002.MMWR Morb Mortal Wkly Rep. 2002 Nov 8;51(44):989-93. MMWR Morb Mortal Wkly Rep. 2002. PMID: 12455906
-
[Surveillance system for adverse events following immunization against yellow fever in Burkina Faso in 2008. Good practice recommendations].Med Trop (Mars). 2009 Aug;69(4):320-1. Med Trop (Mars). 2009. PMID: 19725376 French.
-
Acute viscerotropic disease following vaccination against yellow fever.Trans R Soc Trop Med Hyg. 2007 Oct;101(10):967-71. doi: 10.1016/j.trstmh.2007.06.013. Epub 2007 Jul 31. Trans R Soc Trop Med Hyg. 2007. PMID: 17669451 Review.
-
Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX.Vaccine. 2004 Jun 2;22(17-18):2103-5. doi: 10.1016/j.vaccine.2004.01.026. Vaccine. 2004. PMID: 15149765
-
Yellow fever-associated viscerotropic disease in Barcelona, Spain.J Travel Med. 2008 May-Jun;15(3):202-5. doi: 10.1111/j.1708-8305.2008.00209.x. J Travel Med. 2008. PMID: 18494699 Review.
Cited by
-
Current Assessment of Yellow Fever and Yellow Fever Vaccine.Curr Infect Dis Rep. 2004 Apr;6(2):96-104. doi: 10.1007/s11908-996-0005-9. Curr Infect Dis Rep. 2004. PMID: 15023271
-
Yellow Fever Immunizations: Indications and Risks.Curr Infect Dis Rep. 2004 Feb;6(1):34-42. doi: 10.1007/s11908-004-0022-5. Curr Infect Dis Rep. 2004. PMID: 14733847
-
Prevention of infectious diseases among international pediatric travelers: considerations for clinicians.Semin Pediatr Infect Dis. 2004 Jul;15(3):137-49. doi: 10.1053/j.spid.2004.05.002. Semin Pediatr Infect Dis. 2004. PMID: 15480960 Free PMC article. Review.
-
A humanized monoclonal antibody neutralizes yellow fever virus strain 17D-204 in vitro but does not protect a mouse model from disease.Antiviral Res. 2016 Jul;131:92-9. doi: 10.1016/j.antiviral.2016.04.013. Epub 2016 Apr 26. Antiviral Res. 2016. PMID: 27126613 Free PMC article.
-
STATEMENT FOR TRAVELLERS AND YELLOW FEVER: An Advisory Committee Statement (ACS) Committee to Advise on Tropical Medicine and Travel (CATMAT).Can Commun Dis Rep. 2013 Mar 5;39(ACS-2):1-20. doi: 10.14745/ccdr.v39i00a02. eCollection 2013 Mar 5. Can Commun Dis Rep. 2013. PMID: 31682650 Free PMC article. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
